About Andrew R. Gallimore

Dr. Andrew Gallimore is a computational neurobiologist, pharmacologist, chemist, and writer who has been interested in the neural basis of psychedelic drug action for many years and is the author of a range of articles and research papers on the powerful psychedelic drug, N,N-dimethyltryptamine (DMT), as well as other psychedelics. He recently collaborated with DMT pioneer Dr. Rick Strassman, author of DMT: The Spirit Molecule, to develop a pharmacokinetic model of DMT as the basis of a target-controlled intravenous infusion protocol for extended journeys in DMT space. His current interests focus on DMT as a tool for gating access to extradimensional realities and how this can be understood in terms of the neuroscience of information. He currently lives and works in Japan.